Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureDebopriya Chakraborty, Liam L Donnelly, Joel A Lefferts, Donald C Green, Patrick M Shannon, Martha Quezado, Ziedulla Abdullaev, Kenneth D Aldape, Chun-Chieh Lin
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor
10.18632/oncotarget.8067 · 2016
When “peripheral” becomes “central”: primary and secondary malignant intracerebral nerve sheath tumor: a case report and a systematic review
10.1093/neuros/nyab043 · 2021
Malignant intracerebral nerve sheath tumors: a case report with review of the literature
2013
[Malignant intracerebral nerve sheath tumours: two case reports and complete review of the literature cases]
2016
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
10.1038/nature09730 · 2011
The CREBBP acetyltransferase is a haploinsufficient tumor suppressor in B-cell lymphoma
10.1158/2159-8290.cd-16-1417 · 2017
Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells
10.1016/j.tcb.2014.03.005 · 2014
Neurofibromatosis type 1
10.1038/nrdp.2017.4 · 2017
Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas
10.1093/neuonc/noz028 · 2019
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors
10.1038/ng.3095 · 2014
A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups
10.1182/blood-2008-07-166801 · 2009
Comprehensive molecular characterization of muscle-invasive bladder cancer
10.1016/j.cell.2017.09.007 · 2017
Genetic progression in gastrointestinal stromal tumors: mechanisms and molecular interventions
10.18632/oncotarget.16014 · 2017
Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities
10.1038/s41467-023-38432-6 · 2023
Fusions involving BCOR and CREBBP are rare events in infiltrating glioma
10.1186/s40478-020-00951-4 · 2020
CNS tumor with CREBBP::BCORL1 fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors
10.1186/s40478-024-01726-x · 2024
CREBBP knockdown enhances RAS/RAF/MEK/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response
10.3324/haematol.2016.145177 · 2017
KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia
10.1038/leu.2015.107 · 2015
No additional external references are available.